Grant M. Gallagher

As of January 5, 2020 there have been 59 confirmed cases associated with the pneumonia outbreak in Wuhan city.

A new study found that the estimated time from HIV seroconversion to initiation of ART was reduced by 42% between 2006 and 2015 in New York City.

A new retrospective cohort study has confirmed that rates of hospitalization for serious infections among people with substance use disorders are increasing, particularly among young people.

New findings provide insight on the mechanisms of malarial resistance, demonstrating that inactivation or mutation of Kelch13 compartment proteins reduces the parasite’s uptake of hemoglobin.

A study in JAMA Pediatrics suggests that infants exposed to Zika in utero who do not show signs of congenital Zika syndrome may still be at risk for abnormal neurodevelopmental outcomes.

A new article in Open Forum Infectious Diseases outlines practical strategies for treating opioid use disorder in the context of associated infectious diseases.

Earlier initiation of DAP-CPT combination therapy may be beneficial, despite a tendency to use the therapy after initial treatment failure.

A new study published in the Journal of Clinical Investigation may offer some insight on why past efforts to develop a vaccine for S aureus have failed.

Despite children’s higher risk of complications from influenza, few US child care centers report influenza vaccine requirements for children and/or adult care workers.

The CDC MMWR provides a summary of the Ebola response from August 2018 to November 2019, noting 2196 deaths and consistent challenges in outbreak control due to government mistrust and ongoing armed conflict.

Investigators of a new, multisite study evaluating neuropsychological development in African school-age kids found that children with perinatally-acquired HIV had poorer results on neuropsychological tests despite early ART initiation and viral suppression.

Rapid diagnostic tests provide a potential alternative for diagnosis of Chagas disease in the context of material constraints.

CDC has detailed the first reported case of Shewanella haliotis in the region of the Americas, describing a 2018 case in Flushing, New York.

A meta-analysis of seroprevalence rates estimates that one-fifth of the world’s population carries antibodies against Toxocara.

The MMWR contains new recommendations pertaining to large scale emergency response protocols.

Public health officials are investigating a multistate outbreak of Listeria monocytogenes infections that have caused 4 hospitalizations and 1 death.

An analysis shows that during 2016-17, 14% of people living with HIV have used a drug-cost saving strategy and 7% have had cost saving-related nonadherence.

The US Centers for Disease Control and Prevention is investigating an outbreak of multidrug-resistant human Campylobacter jejuni infections linked to contact with puppies from pet stores, including Petland.

Investigators assessing how frequently antibiotics are prescribed without a documented indication discovered that 18% of antibiotic prescriptions had no documented indication in a nationally representative sample of ambulatory clinic encounters.

Results suggest that PrEP provision is concentrated among those at high risk for HIV and STIs, but that more must be done to prevent STIs among those who persistently use PrEP.

Mouse models suggest that giving patients with cancer a dose of vancomycin before radiation may prepare the immune system to attack tumor cells more effectively.

Investigators have documented growing acceptability among sexual minority men that U=U, but with widespread overestimation of transmission risk.

The FDA investigation of fruit mix linked to a recent outbreak has discovered 33 laboratory confirmed illnesses of Salmonella thus far.

In a phase 3 study comparing delafloxacin and moxifloxacin for community acquired bacterial pneumonia, delafloxacin was deemed well tolerated and effective by investigators.

The Typhoid Vaccine Acceleration Consortium reports that a single dose of a typhoid conjugate vaccine was effective in children aged 9 months to 16 years.

CDC investigators used HIV surveillance and pharmacy data to examine the status of HIV treatment and prevention in the United States.

On December 3, 2019, the US Department of Health and Human Services announced the launch of program which will provide PrEP to people without prescription drug insurance coverage.

The PALM trial evaluated the safety and efficacy of several experimental treatments for Ebola in the Democratic Republic of Congo.

Authors of a new report published by CDC detail barriers to case-based surveillance in policy and technical infrastructure which need to be addressed in order to enhance national efforts surrounding the HIV epidemic.

Results from a new study indicate that early antiretroviral therapy treatment provides measurable benefits in infants who acquired HIV via vertical transmission.